about
The mood disorder questionnaire improves recognition of bipolar disorder in psychiatric careAltered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis.Inflammation theories in psychotic disorders: a critical review.Diabetes and Schizophrenia.Newborn Brain Function Is Affected by Fetal Exposure to Maternal Serotonin Reuptake Inhibitors.Temperament and character traits predict future burden of depression.Temperament, character, and suicide attempts in unipolar and bipolar mood disorders.Predictors of long-term work disability among patients with type I and II bipolar disorder: a prospective 18-month follow-up study.Personality disorders and suicide attempts in unipolar and bipolar mood disorders.Incidence and predictors of suicide attempts in bipolar I and II disorders: A 5-year follow-up study.Gender differences in bipolar disorder type I and II.White matter hyperintensities and cognitive performance in adult patients with bipolar I, bipolar II, and major depressive disorders.Early age at onset of bipolar disorder is associated with more severe clinical features but delayed treatment seeking.A prospective latent analyses study of psychiatric comorbidity of DSM-IV bipolar I and II disorders.Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.Differences in incidence of suicide attempts during phases of bipolar I and II disorders.Differences in incidence of suicide attempts between bipolar I and II disorders and major depressive disorder.Childhood adversities and clinical symptomatology in first-episode psychosis.Hopelessness across phases of bipolar I or II disorder: a prospective study.Prospective study of risk factors for attempted suicide among patients with bipolar disorder.Suicidal behaviour during different phases of bipolar disorder.Early insulin resistance predicts weight gain and waist circumference increase in first-episode psychosis--A one year follow-up study.C-reactive protein and cardiovascular risk in bipolar disorder patients: A systematic review.Mortality in people with psychotic disorders in Finland: A population-based 13-year follow-up study.Dangerously mixed.Anti-neuronal anti-bodies in patients with early psychosis.Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response.Prevalence of current anxiety disorders in people with bipolar disorder during euthymia: a meta-analysis.Cortical salience network activation precedes the development of delusion severity.Five-year outcome of bipolar I and II disorders: findings of the Jorvi Bipolar Study.Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders - an 18-month prospective study.Temperament, character and personality disorders.A prospective latent analysis study of Axis I psychiatric co-morbidity of DSM-IV major depressive disorder.Major depressive disorder and white matter abnormalities: a diffusion tensor imaging study with tract-based spatial statistics.Do antidepressants change personality?--a five-year observational study.Typology of clinical course in bipolar disorder based on 18-month naturalistic follow-up.Neuroticism mediates the effect of P2RX7 on outcomes of mood disorders.Concomitants of family histories of mood disorders and alcoholism in a clinical cohort of patients with bipolar I and II disorder.P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts.
P50
Q24792074-3674F338-1585-4C96-A326-9B20EAEBFD31Q35603078-C1729384-C76C-4741-AA25-2A102A0C97DAQ37648311-61F3C6C5-FDA4-40A6-9C1B-4F475482F324Q38109914-30F74916-C024-4257-8DAF-019AFB66D138Q38709352-E399B274-B194-4A18-86D0-8936F68FA949Q38857229-0771D399-C012-49EA-B77E-2DA4039360CDQ39225639-1287B03E-36DC-41EE-B5D5-549820B3E8E1Q40076276-22D1D7CD-68DB-4C34-839E-6780F4A9A98FQ40259440-1EEF845A-64E3-47EF-8379-A3BE62FC62B6Q40293782-DE7ED440-6EDF-4163-B2EF-BA58628897BAQ40345210-0B4E75A5-2D79-4E2C-9A2F-3202068CCAF7Q44295197-F2FE6C32-5C9F-47B4-BF77-2E451BDC6ACAQ44607240-BA370FEE-3DC1-4591-BD22-A26B9B024C5AQ44749329-1A007E69-3777-455D-8D5A-94A6C0BE5CE8Q44783566-F14659C6-A0F8-44AC-9389-548FD4F87BD4Q45982237-6BE96308-1437-4FD1-BB64-14912D306E7FQ46562272-D041E09C-4C7B-4412-98EE-EB5EC19CE3BEQ46669732-3F3B65E8-2C6F-4343-82F2-3AB954C2703FQ47281239-3F00B17B-259D-4588-8EB2-BE40F97940F8Q47336934-7FC8760E-F275-492A-98BB-FD9F154C2D35Q47339854-B0EC7FAF-5C86-4060-A0F1-AD419196C88FQ47340265-3AD648EA-A652-4D5F-8C30-F9AA83B2CEF4Q47345748-CA2F2A16-F5FA-47D9-9921-2DD27008A88BQ47656183-8EB37E0A-E51F-4945-BABA-444A7307A7EDQ47724274-E6AF8C20-86F1-4737-BB12-E892574CB6D8Q47726056-26CAC020-231C-4046-8B0B-442E08F5DE66Q47735045-6C826648-D5FF-4719-95DB-97FFA088288BQ47740369-F575265C-CF1A-4B94-BBDE-859E3FDCBF2EQ47848081-203C56B6-4141-4FC9-882F-3048D75EBBA7Q47980947-04CB8087-B4CE-476B-BA3E-ED2C7BDE06E6Q48105673-2542A9A8-9501-4D91-93D4-999835984356Q48397121-4C89B762-86FC-4385-83FF-62E6EA172C17Q48432581-54A94B76-5D49-4FE8-8745-4E3FED49DBDDQ48452509-FB7161FB-038B-41A4-8E9C-09DEF13B77AAQ48600636-8AF2176B-1492-43D1-BF5F-DDEFA8BC1AEDQ48636590-8F80B988-4568-4A53-B130-B0AC55B0CB73Q48642780-A6115869-C4DF-4336-8B3D-68E0E633EB44Q48675717-7F164999-F962-412B-AEFE-0FCFE0BFF92FQ48687066-6870E998-C161-4D9B-A912-4A5EE1234107Q48886401-B57F8D8D-7238-4601-B455-9DAB36D6E0DE
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Outi Mantere
@ast
Outi Mantere
@en
Outi Mantere
@es
Outi Mantere
@nl
Outi Mantere
@sl
type
label
Outi Mantere
@ast
Outi Mantere
@en
Outi Mantere
@es
Outi Mantere
@nl
Outi Mantere
@sl
prefLabel
Outi Mantere
@ast
Outi Mantere
@en
Outi Mantere
@es
Outi Mantere
@nl
Outi Mantere
@sl
P106
P1153
6507989373
P21
P31
P496
0000-0002-0383-7215
P569
2000-01-01T00:00:00Z